Navigation Links
First Online Job Fair for Postgraduate Life Scientists Opens
Date:8/2/2011

SANTA CRUZ, Calif., Aug. 2, 2011 /PRNewswire/ -- Bio Careers opened the Virtual Job Summit, the first online job fair for postgraduate life scientists yesterday.  The Job Summit features biotech and academic employers like MedImmune and St. Judes in virtual booths and top jobseekers holding at least a Master's Degree.

The Virtual Job Summit will enable employers to recruit seasoned postgraduate life scientists from the top 15 percent of U.S. training institutions. Employers will be able to upload brochures, white papers, videos and webinar recordings to their virtual booths. Jobseekers will be able to browse among employers, download information and return during the two-day live event on October 5 and 6 to speak with employers via video chat.

"For employers, this will be the most efficient, cost-effective way to recruit top-level, work-experienced, postgraduate life scientists," said President Nick Folger. "For jobseekers, it's an opportunity to research and meet employers that are geographically distant."

Employers can reach out to Bio Careers 35 Member communities across the U.S. without incurring the time and expense of traveling to multiple locations.  All 35 Universities are among the top in the U.S. in life science program rankings.

Bio Careers (www.BioCareers.com) has a database of registered jobseekers from 35 of the top 50 life science graduate programs.  75 percent of these are alumni with up to 15 years of experience.  80 percent hold a Ph.D.  Early jobseeker registrations for the Job Summit are running substantially ahead of expectations, according to Folger.

Jobseekers will also enjoy a series of Webinar broadcasts and a Jobseeker Lounge, where they can video chat with each other about their experiences.

For Jobseeker or Employer registration and other information, please visit www.biocareers.com/virtual-job-summit or contact Marina Enachi at (877) 862-4656, Ext. 116.

About Bio Careers

Bio Careers is the first and only career service dedicated to expanding professional options for life science Ph.D.s and M.D.s. It provides online career resources and job postings to postgraduate and alumni candidates, as well as recruitment services to employers.  Founded in 2006, the company is headquartered in Santa Cruz, Calif.

Media Contact: Marina Enachi, Marketing Director
Direct Phone: (877) 862-4656, Ext. 116
Direct Email: marina@biocareers.com


'/>"/>
SOURCE Bio Careers
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):